Dr. Alexander D. Colevas, MD
Medical Oncology (Medical Oncology Physician)
300 Pasteur Dr
Palo Alto, CA 94304
Who else practices at this address →
Santa Clara County includes mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Harvey Medical College
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 258
Licensed in California since 2007, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- —Medical school: Harvey Medical College
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Medical Oncology Physician primary
CA license C52711 (first issued 2007; current) -
Hematology & Oncology Physician
MD license D0041607
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Stanford Health Care Stanford, CA
- Stanford Health Care Tri-Valley Pleasanton, CA
Medical groups
- Stanford Health Care (3,122 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 258
- Services billed
- 1,396
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 367 | 115 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 89 | 24 |
| Established patient office or other outpatient visit, 30-39 minutes | 76 | 45 |
| Diagnostic exam of voice box using a flexible endoscope | 44 | 39 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 29 | 27 |
| New patient office or other outpatient visit, 60-74 minutes | 29 | 29 |
| Hospital discharge day management, more than 30 minutes | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levothyroxine Sodium Other prescribers in Palo Alto, CA | 40 |
| Gabapentin Other prescribers in Palo Alto, CA | 22 |
| Lenvima (lenvatinib mesylate) | 20 |
| Eliquis (apixaban) Other prescribers in Palo Alto, CA | 19 |
| Dexamethasone Other prescribers in Palo Alto, CA | 16 |
| Ondansetron Hcl Other prescribers in Palo Alto, CA | 15 |
| Prochlorperazine Maleate Other prescribers in Palo Alto, CA | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $117 in total to this clinician.
| Aveo Pharmaceuticals, Inc. | $117 |
|---|
| Food and Beverage | $117 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $280,108 in research payments for these studies, mostly to the institutions running them.
- SRF114-101
Coherus Oncology, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.